Recombinant Mouse ALCAM
| Code | Size | Price |
|---|
| LEI-A337-50ug | 50 ug | £614.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.
Further Information
Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives.
Long Description:
Activated leukocyte cell adhesion molecule (ALCAM/CD166) is an 82 kDa transmembrane glycoprotein and a member of the immunoglobulin gene superfamily. It is also known as MEMD, SC-1/DM-GRASP and KG-CAM. It is linked with cell migration and development and with cancer progression (1). ALCAM is expressed on natural killer cells, thymocytes, platelets, B cells, T cells and monocytes after cell activation, as well as eosinophils, fibroblasts, endothelial cells, keratinocytes and neurons (2). It is a ligand for CD6 and NgCAM but also engages in homophilic interactions.
ALCAM/CD6 interaction plays a role in T cell development and T cell regulation (3).
NCBI Gene:
11658
Purity:
>95% by SDS-PAGE and analyzed by silver stain.
Target:
ALCAM
References
1. Weichert, W. et al. (2004) J. Clin. Pathol. 57:1160
2. Bowen, MA. et al. (1995) J. Exp. Med. 181:2213
3. Aruffo, A. et al. (1997) Immunol. Today 18:498
Related Products
| Product Name | Product Code | Supplier | Anti-Human ALCAM (Clone 105901) | LEI-A381 | Leinco Technologies | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human ALCAM | LEI-A388 | Leinco Technologies | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||